CIK 0001740279 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
IN8BIO, INC.
Sign in to watch- Ticker
- INAB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 825462585
- Phone
- (646) 600-6438
- Business address
- EMPIRE STATE BUILDING, 350 5TH AVENUE, SUITE 5330, NEW YORK, NY, 10118
- Former names
- Incysus Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 68 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-27 | FAIRBAIRN EMILY Director | Gift | −724,637 | 0 | ||
| 2026-05-09 | Graff Jeremy R. Director | Grant or award · Stock Option (right to buy) | +22,000 | 22,000 | ||
| 2026-05-09 | Rochlin Kate President and COO | Grant or award · Employee Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2026-05-09 | McCall Patrick CHIEF FINANCIAL OFFICER | Grant or award · Employee Stock Option (right to buy) | +56,250 | 56,250 | ||
| 2026-05-09 | Greenwood Luba Director | Grant or award · Stock Option (right to buy) | +22,000 | 22,000 | ||
| 2026-05-09 | Epperly Corinne Director | Grant or award · Stock Option (right to buy) | +22,000 | 22,000 | ||
| 2026-05-09 | Ho William Tai-Wei CEO | Grant or award · Employee Stock Option (right to buy) | +154,500 | 154,500 | ||
| 2026-05-09 | Lamb Lawrence EVP and CSO | Grant or award · Employee Stock Option (right to buy) | +54,000 | 54,000 | ||
| 2026-05-09 | FAIRBAIRN EMILY Director | Grant or award · Stock Option (right to buy) | +22,000 | 22,000 | ||
| 2026-05-09 | Brandt Peter C. Director | Grant or award · Stock Option (right to buy) | +22,000 | 22,000 | ||
| 2026-02-04 | Rochlin Kate President and COO | Grant or award · Employee Stock Option (right to buy) | +80,000 | 80,000 | ||
| 2026-02-04 | McCall Patrick CHIEF FINANCIAL OFFICER | Grant or award · Employee Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2026-02-04 | Ho William Tai-Wei CEO | Grant or award · Employee Stock Option (right to buy) | +206,000 | 206,000 | ||
| 2026-02-04 | Lamb Lawrence EVP and CSO | Grant or award · Employee Stock Option (right to buy) | +72,000 | 72,000 | ||
| 2025-12-22 | Rochlin Kate Chief Operating Officer | Grant or award | +7,247 | $1.38 | $10K | 9,085 |
| 2025-12-22 | McCall Patrick CHIEF FINANCIAL OFFICER | Grant or award | +7,247 | $1.38 | $10K | 9,482 |
| 2025-12-22 | Ho William Tai-Wei PRESIDENT AND CEO | Grant or award | +36,232 | $1.38 | $50K | 121,168 |
| 2025-12-22 | FAIRBAIRN EMILY Director | Grant or award | +724,637 | $1.38 | $1000K | 724,637 |
| 2025-12-22 | Roemer Alan S. Director | Grant or award | +36,232 | $1.38 | $50K | 49,514 |
| 2025-12-22 | Brandt Peter C. Director | Grant or award | +72,464 | $1.38 | $100K | 95,181 |
Page 1 of 9 · 179 trades